Monitor Closely (one)viloxazine will enhance the level or effect of phenobarbital by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic effect of elbasvir/grazoprevir could be lowered if coadministered with strong CYP3A inducers and is therefore contraindica